1. Home
  2. INBX
  3. INBX News

Latest Inhibrx Inc. (INBX) News on April 23, 2025

INBX

MT Newswires

21 days ago

Inhibrx Biosciences Signs Deal With Outgoing CSO Brendan Eckelman's New Venture

Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President
INBX

PR Newswire

21 days ago

Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President

Inhibrx Biosciences Full Year 2024 Earnings: Beats Expectations
INBX

Simply Wall St.

a month ago

Inhibrx Biosciences Full Year 2024 Earnings: Beats Expectations

Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results
INBX

PR Newswire

a month ago

Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results

INBX

MT Newswires

3 months ago

Inhibrx Prospective Colorectal Cancer Treatment Shows Encouraging Results, Trial Expansion Planned

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer
INBX

PR Newswire

3 months ago

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance
INBX

PR Newswire

3 months ago

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance

INBX

MT Newswires

5 months ago

Inhibrx Biosciences Insider Bought Shares Worth $1,523,620, According to a Recent SEC Filing

The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares
INBX

Simply Wall St.

5 months ago

The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
INBX

PR Newswire

5 months ago

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation
INBX

PR Newswire

6 months ago

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation

INBX

Argus Research

6 months ago

Daily – Vickers Top Buyers & Sellers for 10/08/2024

INBX

MT Newswires

7 months ago

Inhibrx Biosciences Insider Bought Shares Worth $629,117, According to a Recent SEC Filing

INBX

GuruFocus.com

7 months ago

Director Kristiina Vuori Purchases Shares of Inhibrx Biosciences Inc (INBX)

INBX

MT Newswires

8 months ago

Inhibrx Biosciences Insider Bought Shares Worth $1,037,328, According to a Recent SEC Filing

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
INBX

PR Newswire

8 months ago

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

INBX

MT Newswires

a year ago

Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing

INBX

MT Newswires

a year ago

Inhibrx Shareholders Approve Sale of INBRX-101 Assets to Sanofi

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
INBX

PR Newswire

a year ago

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
INBX

PR Newswire

a year ago

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off

Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger
INBX

PR Newswire

a year ago

Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger

Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates
INBX

Zacks

a year ago

Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
INBX

PR Newswire

a year ago

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?
INBX

Zacks

a year ago

Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit
INBX

Barrons.com

a year ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY
INBX

GlobeNewswire

a year ago

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY

Forget Palantir: 2 Artificial Intelligence (AI) Stocks to Buy Instead
INBX

Motley Fool

a year ago

Forget Palantir: 2 Artificial Intelligence (AI) Stocks to Buy Instead

Gentex Corporation (NASDAQ:GNTX) Q4 2023 Earnings Call Transcript
INBX

Insider Monkey

a year ago

Gentex Corporation (NASDAQ:GNTX) Q4 2023 Earnings Call Transcript

Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX
INBX

Zacks

a year ago

Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX

Sensient Technologies (NYSE:SXT) Has Affirmed Its Dividend Of $0.41
INBX

Simply Wall St.

a year ago

Sensient Technologies (NYSE:SXT) Has Affirmed Its Dividend Of $0.41

Biotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More
INBX

Zacks

a year ago

Biotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More

Inhibrx, Inc. (INBX) Soars 8.9%: Is Further Upside Left in the Stock?
INBX

Zacks

a year ago

Inhibrx, Inc. (INBX) Soars 8.9%: Is Further Upside Left in the Stock?

Health Care Roundup: Market Talk
INBX

The Wall Street Journal

a year ago

Health Care Roundup: Market Talk

These Stocks Moved the Most Today: United, 3M, Verizon, Plug Power, Johnson & Johnson, GE, and More
INBX

Barrons.com

a year ago

These Stocks Moved the Most Today: United, 3M, Verizon, Plug Power, Johnson & Johnson, GE, and More

Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It
INBX

Investor's Business Daily

a year ago

Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It

Inhibrx (INBX) Up 6% on Sale of Rare Disease Drug to Sanofi
INBX

Zacks

a year ago

Inhibrx (INBX) Up 6% on Sale of Rare Disease Drug to Sanofi

Survey Reveals 55% of CXM Leaders Plan to Invest $1 Million or more in GenAI in Next 12-18 Months
INBX

Business Wire

a year ago

Survey Reveals 55% of CXM Leaders Plan to Invest $1 Million or more in GenAI in Next 12-18 Months

Sanofi to buy Inhibrx in deal worth up to $2.2B
INBX

BioPharma Dive

a year ago

Sanofi to buy Inhibrx in deal worth up to $2.2B

Is CNO Financial Group (CNO) Stock Undervalued Right Now?
INBX

Zacks

a year ago

Is CNO Financial Group (CNO) Stock Undervalued Right Now?

Crinetics Pharmaceuticals Inc Insider Sells Shares
INBX

GuruFocus.com

a year ago

Crinetics Pharmaceuticals Inc Insider Sells Shares

A Closer Look At Atlantica Sustainable Infrastructure plc's (NASDAQ:AY) Uninspiring ROE
INBX

Simply Wall St.

a year ago

A Closer Look At Atlantica Sustainable Infrastructure plc's (NASDAQ:AY) Uninspiring ROE

Main Street Capital (MAIN) Increases Yet Falls Behind Market: What Investors Need to Know
INBX

Zacks

a year ago

Main Street Capital (MAIN) Increases Yet Falls Behind Market: What Investors Need to Know

Arbor Realty Trust (ABR) Ascends But Remains Behind Market: Some Facts to Note
INBX

Zacks

a year ago

Arbor Realty Trust (ABR) Ascends But Remains Behind Market: Some Facts to Note

SiTime to Present at the Needham Growth Conference on January 16, 2024
INBX

GlobeNewswire

a year ago

SiTime to Present at the Needham Growth Conference on January 16, 2024

What Is Nova Ltd.'s (NASDAQ:NVMI) Share Price Doing?
INBX

Simply Wall St.

a year ago

What Is Nova Ltd.'s (NASDAQ:NVMI) Share Price Doing?

Is Array Technologies Stock a Top Buy on the Dip in 2024?
INBX

Motley Fool

a year ago

Is Array Technologies Stock a Top Buy on the Dip in 2024?

Is There Now An Opportunity In Rapid7, Inc. (NASDAQ:RPD)?
INBX

Simply Wall St.

a year ago

Is There Now An Opportunity In Rapid7, Inc. (NASDAQ:RPD)?

Brookfield Acknowledges Result of the Origin Energy Shareholder Vote
INBX

GlobeNewswire

a year ago

Brookfield Acknowledges Result of the Origin Energy Shareholder Vote

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
INBX

Zacks

a year ago

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock

Apple Hospitality REIT Reports Results of Operations for Third Quarter 2023
INBX

Business Wire

a year ago

Apple Hospitality REIT Reports Results of Operations for Third Quarter 2023

Privia Health Group, Inc.'s (NASDAQ:PRVA) P/S Still Appears To Be Reasonable
INBX

Simply Wall St.

a year ago

Privia Health Group, Inc.'s (NASDAQ:PRVA) P/S Still Appears To Be Reasonable

Share on Social Networks: